Y. Chi, and C. Chen. Statistics in medicine, 27 (29):
6175-89(December 2008)5263<m:linebreak></m:linebreak>LR: 20090730; JID: 8215016; 0 (Antineoplastic Agents); 33419-42-0 (Etoposide); ppublish;<m:linebreak></m:linebreak>Fase II.
W. Holden. Drug safety : an international journal of medical toxicology and drug experience, 26 (12):
853-62(January 2003)3513<m:linebreak></m:linebreak>Relació benefici/risc.
J. Snowden, S. Rose, and K. Mortimer. American journal of epidemiology, 173 (7):
731-8(April 2011)6073<m:linebreak></m:linebreak>JID: 7910653; aheadofprint;.
J. Reitsma, K. Moons, P. Bossuyt, and K. Linnet. Clinical chemistry, 58 (11):
1534-45(November 2012)7294<m:linebreak></m:linebreak>CI: (c) 2012; JID: 9421549; 2012/09/18 aheadofprint; ppublish;<m:linebreak></m:linebreak>Proves diagnòstiques; Metaanàlisi.
H. Zhang, E. Triche, and B. Leaderer. American journal of epidemiology, 151 (12):
1206-15(June 2000)4421<m:linebreak></m:linebreak>LR: 20071114; PUBM: Print; GR: ES05410/ES/United States NIEHS; GR: HD30712/HD/United States NICHD; JID: 7910653; 0 (Air Pollutants); ppublish;<m:linebreak></m:linebreak>Sèries temporals.
T. Stürmer, K. Rothman, J. Avorn, and R. Glynn. American journal of epidemiology, 172 (7):
843-54(October 2010)5732<m:linebreak></m:linebreak>JID: 7910653; aheadofprint;<m:linebreak></m:linebreak>Propensity score.